Radioimmunotargeting of Malignant Glioma by Monoclonal Antibody D2C7 Reactive Against Both Wild-Type and Variant III Mutant Epidermal Growth Factor Receptors
Nuclear Medicine and Biology - United States
doi 10.1016/j.nucmedbio.2011.06.005
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2012
Authors
Publisher
Elsevier BV